Matches in Nanopublications for { ?s ?p "[We utilized a replication-defective adenoviral construct containing the beta-galactosidase gene as a control and the herpes simplex virus thymidine kinase gene as the therapeutic vector under the transcription control of the Rous sarcoma virus long terminal repeat promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[We utilized a replication-defective adenoviral construct containing the beta-galactosidase gene as a control and the herpes simplex virus thymidine kinase gene as the therapeutic vector under the transcription control of the Rous sarcoma virus long terminal repeat promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We utilized a replication-defective adenoviral construct containing the beta-galactosidase gene as a control and the herpes simplex virus thymidine kinase gene as the therapeutic vector under the transcription control of the Rous sarcoma virus long terminal repeat promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP514673.RA1SHJ6We3PZmadBbkifjUPCxbDadYZctuZXPkjz5NnOo130_assertion description "[We utilized a replication-defective adenoviral construct containing the beta-galactosidase gene as a control and the herpes simplex virus thymidine kinase gene as the therapeutic vector under the transcription control of the Rous sarcoma virus long terminal repeat promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP514673.RA1SHJ6We3PZmadBbkifjUPCxbDadYZctuZXPkjz5NnOo130_provenance.
- NP427360.RAF7_hhrrs1gwy82aJmyx-7IsQfKT7IedgMfkDshQH0oE130_assertion description "[We utilized a replication-defective adenoviral construct containing the beta-galactosidase gene as a control and the herpes simplex virus thymidine kinase gene as the therapeutic vector under the transcription control of the Rous sarcoma virus long terminal repeat promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427360.RAF7_hhrrs1gwy82aJmyx-7IsQfKT7IedgMfkDshQH0oE130_provenance.
- NP294985.RAyFyhIkJUS1xqzXmr0FEAQVNkUdGlJhF6B9RJyB-IqmA130_assertion description "[We utilized a replication-defective adenoviral construct containing the beta-galactosidase gene as a control and the herpes simplex virus thymidine kinase gene as the therapeutic vector under the transcription control of the Rous sarcoma virus long terminal repeat promoter.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294985.RAyFyhIkJUS1xqzXmr0FEAQVNkUdGlJhF6B9RJyB-IqmA130_provenance.